Severe cerebrovascular and parenchymal lesions in brains of SHRSP were also reduced in both spironolactone- and eplerenone-treated animals[21,22], suggesting that MR inhibition protects against stroke incidence through actions on both vascular and parenchymal tissues. Here, NR3C2 is linked to Stroke.